This website has been developed and funded by Janssen-Cilag Ltd and is intended for UK patients prescribed Stelara® (ustekinumab) only.

myStelara
(ustekinumab)

Stelara® is a type of medicine called an immunosuppressant, which works by modifying parts of your immune system. This can help to reduce the symptoms of psoriasis, psoriatic arthritis, Crohn’s disease and ulcerative colitis which are caused by an overactive immune response.1,2

It is important to only use this medication as prescribed by your healthcare professional and not try to inject yourself until you have been trained by a doctor or a nurse.2 Always follow your clinician's prescribing guidance on the use of this medication. Before using this medicine, please consult the Patient Information Leaflet (PIL) for important information on what Stelara® is, what you need to know before you start your treatment, how to store and use your medication, and what side effects can potentially occur.

Please see the video below for instructions on how to administer Stelara® by injection under the skin (‘subcutaneously’).

Crohn’s Disease

Plaque Psoriasis

Ulcerative Colitis

Psoriatic Arthritis

Please consult the Patient Information Leaflet (PIL) for any further information.

The PIL for patients with Crohn's disease and ulcerative colitis can be found here for patients in Great Britain or for patients in Northern Ireland.
The PIL for patients with psoriatic arthritis and psoriasis can be found here for patients in Great Britain or for patients in Northern Ireland.

Reporting side effects

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet.
You can also report side effects directly via the Yellow Card Scheme at https://yellowcard.mhra.gov.uk/.
By reporting side effects you can help provide more information on the safety of this medicine.

References

  1. Stelara® (ustekinumab) 90mg solution for injection in pre-filled syringe Great Britain Summary of Product Characteristics [Last accessed July 2022]
  2. Stelara® (ustekinumab) 90mg solution for injection in pre-filled syringe Great Britain Patient Information Leaflet [Last accessed July 2022].